Susceptibilities ofCandidaSpecies to Amphotericin B and Fluconazole: The Emergence of Fluconazole Resistance inCandida tropicalis
- 2 January 2004
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 25 (1) , 60-64
- https://doi.org/10.1086/502294
Abstract
Objective:: To determine the susceptibilities ofCandidaspecies isolated from Taiwan to amphotericin B and fluconazole.Design:: Prospective surveillance study.Methods:: Each hospital was asked to submit up to 10C. albicansand 40non-albicans Candidaspecies during the collection period, from April 15 to June 15, 1999. One isolate was accepted from each episode of infection. The broth microdilution method was used to determine susceptibilities to amphotericin B and fluconazole.Results:: Only 3 of 632 isolates, one each ofC. famata, C. krusei,andC. tropicalis,were resistant to amphotericin B. A total of 53 (8.4%) of 632 clinical yeast isolates, consisting of 4%C. albicans,8%C. glabrata,15%C. tropicalis,and 70%C. krusei,were resistant to fluconazole. In contrast, noC. parapsilosisisolate was resistant to fluconazole. Isolates from tertiary-care medical centers had higher rates of resistance to fluconazole than did those from regional and local hospitals (11.4% vs 6.6%). Isolates from different sources showed different levels of susceptibility to fluconazole. All of the isolates with the exception ofC. tropicalisandC. kruseiisolated from blood were susceptible to fluconazole. A pattern of co-resistance to both amphotericin B and fluconazole was observed.Conclusions:: Non-albicans Candidaspecies had higher rates of resistance to fluconazole than didC. albicans(44 of 395 [11.2%] vs 9 of 237 [3.8%];P= .002). The increasing rate of fluconazole resistance inC. tropicalis(15%) is important becauseC. tropicalisis one of the most commonly isolatednon-albicans Candidaspecies.Keywords
This publication has 28 references indexed in Scilit:
- Prospective Study of Candida Species in Patients at a Comprehensive Cancer CenterAntimicrobial Agents and Chemotherapy, 2001
- Prevalence and Antifungal Susceptibility of 442 Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, CanadaJournal of Clinical Microbiology, 2001
- Community-Acquired Fungemia Due to a Multiple-Azole-Resistant Strain of Candida tropicalisClinical Infectious Diseases, 1999
- National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE ProgramDiagnostic Microbiology and Infectious Disease, 1998
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections at a Teaching Hospital in Taiwan, 1981 to 1993Infection Control & Hospital Epidemiology, 1997
- RISK FACTORS OF INVASIVE CANDIDA AND NON-CANDIDA FUNGAL INFECTIONS AFTER LIVER TRANSPLANTATION1Transplantation, 1996
- Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in miceAntimicrobial Agents and Chemotherapy, 1995
- High prevalence of antifungal resistance in Candida spp. from patients with AIDSJournal of Antimicrobial Chemotherapy, 1994
- Molecular mechanisms of drug resistance in fungiTrends in Microbiology, 1994
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993